Minoryx Therapeutics
SpainEntry
2022
Hold
4yr
Status
Active
Who owns Minoryx Therapeutics?
Minoryx Therapeutics is currently owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage), since 2022. Across its history, Minoryx Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-03
Most recent investor
Columbus Venture PartnersColumbus Life Science Fund II · 2019 · Life Sciences VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Caixa Capital Risc, Invivo Partners, Ysios Capital Partners and Columbus Venture Partners since 2015.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Caixa Capital Risc, Invivo Partners, Ysios Capital Partners and Columbus Venture Partners since 2015.
Co-invest · 4 holders · 2015 · present
Caixa Capital RiscActive
2015 · present(11yr) · Criteria Bio Ventures · 2002 · VC
Ysios Capital PartnersActive
2015 · present(11yr) · Ysios BioFund II Innvierte · 2016 · Life Sciences VC
Invivo PartnersActive
2015 · present(11yr) · Healthequity · 2012 · Life Sciences VC
More from Columbus Life Science Fund II
Other portfolio companies in the same fund.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Minoryx Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Minoryx Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Minoryx Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue